dostęp otwarty

Tom 13, Nr 6 (2009)
Prace oryginalne
Opublikowany online: 2010-02-26
Pobierz cytowanie

The association between 3020INSC mutation in NOD2 gene and arterial stiffness in hypertensives

Grażyna Szumczyk-Muszytowska, Jacek Manitius, Andrzej Tretyn, Joanna Jarkiewicz-Tretyn, Marek Muszytowski
Nadciśnienie tętnicze 2009;13(6):371-375.

dostęp otwarty

Tom 13, Nr 6 (2009)
Prace oryginalne
Opublikowany online: 2010-02-26

Streszczenie

Background The innate immune system elicits an inflammatory process which is believed to be involved in the development of vascular damage in hypertension. The NOD2 gene (CARD15) is involved in the control of the innate immune system. The aim of this study was to assess the occurrence of the 3020insC mutation in the NOD2 gene in relation to vascular damage in hypertensives. Materials and methods In 466 hypertensives, genotyping for 3020insC mutation, cholesterol, serum creatinine, and echocardiography were carried out. Systolic (SBP) and diastolic (DBP) blood pressure and pulse pressure (PP) were taken at 2-3 month intervals for one year and treated according to ESC/ESH guidelines. Results The 3020insC mutation was found in 7.08% of hypertensives and was associated with earlier onset of hypertension 48.2 ± 12.1 v. 42.8 ± 10.9, p < 0.01 (age of pts). After one year of treatment, patients with the mutation had significantly higher SBP (138.48 ± 18.35 v. 131.74 ± 14.97, p < 0.04) and PP (57.27 ± 14.04 v. 52.70 ± 12.96, p < 0.04) than patients without the mutation, whereas the number of drugs was the same in both groups.
Conclusions The results suggest that the 3020insC mutation is associated with earlier onset of hypertension and increased arterial stiffness.

Streszczenie

Background The innate immune system elicits an inflammatory process which is believed to be involved in the development of vascular damage in hypertension. The NOD2 gene (CARD15) is involved in the control of the innate immune system. The aim of this study was to assess the occurrence of the 3020insC mutation in the NOD2 gene in relation to vascular damage in hypertensives. Materials and methods In 466 hypertensives, genotyping for 3020insC mutation, cholesterol, serum creatinine, and echocardiography were carried out. Systolic (SBP) and diastolic (DBP) blood pressure and pulse pressure (PP) were taken at 2-3 month intervals for one year and treated according to ESC/ESH guidelines. Results The 3020insC mutation was found in 7.08% of hypertensives and was associated with earlier onset of hypertension 48.2 ± 12.1 v. 42.8 ± 10.9, p < 0.01 (age of pts). After one year of treatment, patients with the mutation had significantly higher SBP (138.48 ± 18.35 v. 131.74 ± 14.97, p < 0.04) and PP (57.27 ± 14.04 v. 52.70 ± 12.96, p < 0.04) than patients without the mutation, whereas the number of drugs was the same in both groups.
Conclusions The results suggest that the 3020insC mutation is associated with earlier onset of hypertension and increased arterial stiffness.
Pobierz cytowanie

Słowa kluczowe

arterial stiffness; innate immunity; NOD2 mutation

Informacje o artykule
Tytuł

The association between 3020INSC mutation in NOD2 gene and arterial stiffness in hypertensives

Czasopismo

Arterial Hypertension

Numer

Tom 13, Nr 6 (2009)

Strony

371-375

Data publikacji on-line

2010-02-26

Rekord bibliograficzny

Nadciśnienie tętnicze 2009;13(6):371-375.

Słowa kluczowe

arterial stiffness
innate immunity
NOD2 mutation

Autorzy

Grażyna Szumczyk-Muszytowska
Jacek Manitius
Andrzej Tretyn
Joanna Jarkiewicz-Tretyn
Marek Muszytowski

Ważne: serwis https://journals.viamedica.pl/ wykorzystuje pliki cookies. Więcej >>

Używamy informacji zapisanych za pomocą plików cookies m.in. w celach statystycznych, dostosowania serwisu do potrzeb użytkownika (np. język interfejsu) i do obsługi logowania użytkowników. W ustawieniach przeglądarki internetowej można zmienić opcje dotyczące cookies. Korzystanie z serwisu bez zmiany ustawień dotyczących cookies oznacza, że będą one zapisane w pamięci komputera. Więcej informacji można znaleźć w naszej Polityce prywatności.

Czym są i do czego służą pliki cookie możesz dowiedzieć się na stronie wszystkoociasteczkach.pl.

Czasopismo Nadciśnienie Tętnicze dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl